{"pmid":32504637,"title":"ELEVATED MONOCYTE DISTRIBUTION WIDTH IN COVID-19 PATIENTS: THE CONTRIBUTION OF THE NOVEL SEPSIS INDICATOR.","text":["ELEVATED MONOCYTE DISTRIBUTION WIDTH IN COVID-19 PATIENTS: THE CONTRIBUTION OF THE NOVEL SEPSIS INDICATOR.","INTRODUCTION: Interesting results regarding the contribution of MDW (Monocyte Distribution Width) in the Infectious Disease Unit have been reported. An observational study is ongoing at San Donato Hospital with the aim to evaluate the contribution of MDW in the diagnostic pathway in adult patients entering in the ED setting and tested for SARS-CoV-2. MATERIAL AND METHOD: COVID-19 symptomatic and paucisymptomatic patients presenting to ED (Emergency Department), have been enrolled consecutively. Whole blood venous samples have been collected on K2 EDTA for MDW determination, at the same time a nasopharyngeal swab for SARS-CoV-2 RNA detection have been collected. RESULTS: One hundred six patients were negative for SARS-CoV-2 with MDW mean value of 20.3 +/- 3.3, while forty-one were positive for SARS-CoV-2 with higher MDW mean value of 27.3 +/- 4.9 (P <0.005). The ROC curve analysis has been evaluated showing MDW AUC of 0.91. Finally twenty-three patients hospitalized in high-intensity care unit showed an MDW value higher than the eighteen patients presenting few symptoms [28.8 +/- 5.3 vs 25.4 +/- 3.6 respectively, P<0.05]. DISCUSSION: Monocytic population, in Covid19 disease, are the first elements of innate immunity to be involved, these changes are the basis of the modification of the MDW, with evident efficacy in term of sensitivity, particularly in the studied Covid19 patients. Moreover the patients hospitalized in high-intensity care unit showed significantly elevated MDW respects to middle or low symptomatic one, suggest including this parameter as prognostic marker or of therapy efficacy, integrated with other laboratory findings.","Clin Chim Acta","Ognibene, Agostino","Lorubbio, Maria","Magliocca, Pasqualino","Tripodo, Emanuela","Vaggelli, Guendalina","Iannelli, Giovanni","Feri, Marco","Scala, Raffaele","Polcini Tartaglia, Alessandro","Galano, Angelo","Pancrazzi, Alessandro","Tacconi, Danilo","32504637"],"abstract":["INTRODUCTION: Interesting results regarding the contribution of MDW (Monocyte Distribution Width) in the Infectious Disease Unit have been reported. An observational study is ongoing at San Donato Hospital with the aim to evaluate the contribution of MDW in the diagnostic pathway in adult patients entering in the ED setting and tested for SARS-CoV-2. MATERIAL AND METHOD: COVID-19 symptomatic and paucisymptomatic patients presenting to ED (Emergency Department), have been enrolled consecutively. Whole blood venous samples have been collected on K2 EDTA for MDW determination, at the same time a nasopharyngeal swab for SARS-CoV-2 RNA detection have been collected. RESULTS: One hundred six patients were negative for SARS-CoV-2 with MDW mean value of 20.3 +/- 3.3, while forty-one were positive for SARS-CoV-2 with higher MDW mean value of 27.3 +/- 4.9 (P <0.005). The ROC curve analysis has been evaluated showing MDW AUC of 0.91. Finally twenty-three patients hospitalized in high-intensity care unit showed an MDW value higher than the eighteen patients presenting few symptoms [28.8 +/- 5.3 vs 25.4 +/- 3.6 respectively, P<0.05]. DISCUSSION: Monocytic population, in Covid19 disease, are the first elements of innate immunity to be involved, these changes are the basis of the modification of the MDW, with evident efficacy in term of sensitivity, particularly in the studied Covid19 patients. Moreover the patients hospitalized in high-intensity care unit showed significantly elevated MDW respects to middle or low symptomatic one, suggest including this parameter as prognostic marker or of therapy efficacy, integrated with other laboratory findings."],"journal":"Clin Chim Acta","authors":["Ognibene, Agostino","Lorubbio, Maria","Magliocca, Pasqualino","Tripodo, Emanuela","Vaggelli, Guendalina","Iannelli, Giovanni","Feri, Marco","Scala, Raffaele","Polcini Tartaglia, Alessandro","Galano, Angelo","Pancrazzi, Alessandro","Tacconi, Danilo"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504637","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.cca.2020.06.002","keywords":["covid-19","monocyte distribution width","sars-cov-2"],"locations":["Monocytic"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668892488228667393,"score":9.490897,"similar":[{"pmid":32330291,"title":"Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.","text":["Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.","BACKGROUND: A pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading throughout the world. Though molecular diagnostic tests are the gold standard for COVID-19, serological testing is emerging as a potential surveillance tool, in addition to its complementary role in COVID-19 diagnostics. Indubitably quantitative serological testing provides greater advantages than qualitative tests but today there is still little known about serological diagnostics and what the most appropriate role quantitative tests might play. METHODS: Sixty-one COVID-19 patients and 64 patients from a control group were tested by iFlash1800 CLIA analyzer for anti-SARS CoV-2 antibodies IgM and IgG. All COVID-19 patients were hospitalized in San Giovanni di Dio Hospital (Florence, Italy) and had a positive oro/nasopharyngeal swab RT-PCR result. RESULTS: The highest sensitivity with a very good specificity performance was reached at a cutoff value of 10.0 AU/mL for IgM and of 7.1 for IgG antibodies, hence near to the manufacturer's cutoff values of 10 AU/mL for both isotypes. The ROC performance curves showed area under the curve (AUC) values of 0.918 and 0.980 for anti-SARS CoV-2 antibodies IgM and IgG, respectively. CONCLUSIONS: iFlash1800 CLIA analyzer has shown highly accurate results for the anti-SARS-CoV-2 antibodies profile and can be considered an excellent tool for COVID-19 diagnostics. This article is protected by copyright. All rights reserved.","J Med Virol","Infantino, M","Grossi, V","Lari, B","Bambi, R","Perri, A","Manneschi, M","Terenzi, G","Liotti, I","Ciotta, G","Taddei, C","Benucci, M","Casprini, P","Veneziani, F","Fabbri, S","Pompetti, A","Manfredi, M","32330291"],"abstract":["BACKGROUND: A pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading throughout the world. Though molecular diagnostic tests are the gold standard for COVID-19, serological testing is emerging as a potential surveillance tool, in addition to its complementary role in COVID-19 diagnostics. Indubitably quantitative serological testing provides greater advantages than qualitative tests but today there is still little known about serological diagnostics and what the most appropriate role quantitative tests might play. METHODS: Sixty-one COVID-19 patients and 64 patients from a control group were tested by iFlash1800 CLIA analyzer for anti-SARS CoV-2 antibodies IgM and IgG. All COVID-19 patients were hospitalized in San Giovanni di Dio Hospital (Florence, Italy) and had a positive oro/nasopharyngeal swab RT-PCR result. RESULTS: The highest sensitivity with a very good specificity performance was reached at a cutoff value of 10.0 AU/mL for IgM and of 7.1 for IgG antibodies, hence near to the manufacturer's cutoff values of 10 AU/mL for both isotypes. The ROC performance curves showed area under the curve (AUC) values of 0.918 and 0.980 for anti-SARS CoV-2 antibodies IgM and IgG, respectively. CONCLUSIONS: iFlash1800 CLIA analyzer has shown highly accurate results for the anti-SARS-CoV-2 antibodies profile and can be considered an excellent tool for COVID-19 diagnostics. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Infantino, M","Grossi, V","Lari, B","Bambi, R","Perri, A","Manneschi, M","Terenzi, G","Liotti, I","Ciotta, G","Taddei, C","Benucci, M","Casprini, P","Veneziani, F","Fabbri, S","Pompetti, A","Manfredi, M"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330291","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25932","keywords":["coronavirus","humoral immunity","immune responses","sars coronavirus","virus classification"],"locations":["San Giovanni","Florence","Italy","analyzer","Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494570856448,"score":195.36794},{"pmid":32271369,"pmcid":"PMC7184473","title":"Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score.","text":["Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score.","BACKGROUND: We aimed to clarify the high-risk factors with multivariate analysis and establish a prediction of disease progression, so as to help clinicians to better choose therapeutic strategy. METHODS: All the consecutive patients with COVID-19 admitted to Fuyang second people's hospital or the fifth medical center of Chinese PLA general hospital between January 20 and February 22, 2020, were enrolled and their clinical data were retrospectively collected. Multivariate COX regression was used to identify the risk factors associated with progression, and then were incorporated into the nomogram to establish a novel prediction scoring model. ROC was used to assess the performance of the novel model. RESULTS: Overall, 208 patients were divided into stable group (n=168, 80.8%) and progressive group (n=40,19.2%) based on whether their conditions worsened during the hospitalization Univariate and multivariate analysis showed that comorbidity, older age, lower lymphocyte and higher lactate dehydrogenase at presentation were independent high-risk factors for COVID-19 progression. Incorporating these 4 factors, the nomogram achieved good concordance indexes of 0.86 (95%CI 0.81 - 0.91), and had well-fitted calibration curves. A novel scoring model, named as CALL, was established, and its area under ROC was 0.91 (95% CI 0.86 to 0.94). Using a cutoff value of 6 points, the positive and negative predictive values were 50.7% (38.9% - 62.4%) and 98.5% (94.7% - 99.8%), respectively. CONCLUSION: Using the CALL score model, clinicians can improve the therapeutic effect and reduce the mortality of COVID-19 with more accurate and reasonable resolutions on medical resources.","Clin Infect Dis","Ji, Dong","Zhang, Dawei","Xu, Jing","Chen, Zhu","Yang, Tieniu","Zhao, Peng","Chen, Guofeng","Cheng, Gregory","Wang, Yudong","Bi, Jingfeng","Tan, Lin","Lau, George","Qin, Enqiang","32271369"],"abstract":["BACKGROUND: We aimed to clarify the high-risk factors with multivariate analysis and establish a prediction of disease progression, so as to help clinicians to better choose therapeutic strategy. METHODS: All the consecutive patients with COVID-19 admitted to Fuyang second people's hospital or the fifth medical center of Chinese PLA general hospital between January 20 and February 22, 2020, were enrolled and their clinical data were retrospectively collected. Multivariate COX regression was used to identify the risk factors associated with progression, and then were incorporated into the nomogram to establish a novel prediction scoring model. ROC was used to assess the performance of the novel model. RESULTS: Overall, 208 patients were divided into stable group (n=168, 80.8%) and progressive group (n=40,19.2%) based on whether their conditions worsened during the hospitalization Univariate and multivariate analysis showed that comorbidity, older age, lower lymphocyte and higher lactate dehydrogenase at presentation were independent high-risk factors for COVID-19 progression. Incorporating these 4 factors, the nomogram achieved good concordance indexes of 0.86 (95%CI 0.81 - 0.91), and had well-fitted calibration curves. A novel scoring model, named as CALL, was established, and its area under ROC was 0.91 (95% CI 0.86 to 0.94). Using a cutoff value of 6 points, the positive and negative predictive values were 50.7% (38.9% - 62.4%) and 98.5% (94.7% - 99.8%), respectively. CONCLUSION: Using the CALL score model, clinicians can improve the therapeutic effect and reduce the mortality of COVID-19 with more accurate and reasonable resolutions on medical resources."],"journal":"Clin Infect Dis","authors":["Ji, Dong","Zhang, Dawei","Xu, Jing","Chen, Zhu","Yang, Tieniu","Zhao, Peng","Chen, Guofeng","Cheng, Gregory","Wang, Yudong","Bi, Jingfeng","Tan, Lin","Lau, George","Qin, Enqiang"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271369","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1093/cid/ciaa414","keywords":["covid-19","coronavirus","nomogram","prediction"],"locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491869724672,"score":182.95673},{"pmid":32445579,"title":"Prognostic value of C-reactive protein in patients with COVID-19.","text":["Prognostic value of C-reactive protein in patients with COVID-19.","BACKGROUND: Elevated serum C-reactive protein (CRP) level was observed in most patients with COVID-19. METHODS: Data of COVID-19 patients with clinical outcome in a designated hospital in Wuhan, China, were retrospectively collected and analyzed from Jan 30 to Feb 20, 2020. The prognostic value of admission CRP was evaluated in patients with COVID-19. RESULTS: Out of 298 patients enrolled, 84 died and 214 recovered. Most non-survivors tended to be males, old aged, or with chronic diseases. Compared to survivors, non-survivors showed significantly elevated white blood cell and neutrophil count, neutrophil to lymphocyte ratio (NLR), systemic immune-inflammation index (SII, defined by platelet count multiply by NLR), CRP, procalcitonin, and D-dimer, and decreased red blood cell, lymphocyte, and platelet count. Age, neutrophil count, platelet count, and CRP were identified as independent predictors of adverse outcome. The area under the receiver operating characteristic (ROC) curve (AUC) of CRP (0.896) was significantly higher than that of age (0.833), neutrophil count (0.820), and platelet count (0.678) in outcome prediction (all p<0.05). With a cut-off value of 41.4, CRP exhibited sensitivity 90.5%, specificity 77.6%, positive predictive value 61.3%, and negative predictive value 95.4%. Subgroup analysis revealed that CRP remained robust accuracy in adverse outcome prediction in patients with different disease severity (AUC 0.832, z=10.23, p<0.001; AUC 0.989, z=44.04, p<0.001). CRP was also an independent discriminator of severe/critical illness on admission (AUC 0.783, z=10.69, p<0.001). CONCLUSIONS: In patients with COVID-19, admission CRP correlated with disease severity and tended to be a good predictor of adverse outcome.","Clin Infect Dis","Luo, Xiaomin","Zhou, Wei","Yan, Xiaojie","Guo, Tangxi","Wang, Benchao","Xia, Hongxia","Ye, Lu","Xiong, Jun","Jiang, Zongping","Liu, Yu","Zhang, Bicheng","Yang, Weize","32445579"],"abstract":["BACKGROUND: Elevated serum C-reactive protein (CRP) level was observed in most patients with COVID-19. METHODS: Data of COVID-19 patients with clinical outcome in a designated hospital in Wuhan, China, were retrospectively collected and analyzed from Jan 30 to Feb 20, 2020. The prognostic value of admission CRP was evaluated in patients with COVID-19. RESULTS: Out of 298 patients enrolled, 84 died and 214 recovered. Most non-survivors tended to be males, old aged, or with chronic diseases. Compared to survivors, non-survivors showed significantly elevated white blood cell and neutrophil count, neutrophil to lymphocyte ratio (NLR), systemic immune-inflammation index (SII, defined by platelet count multiply by NLR), CRP, procalcitonin, and D-dimer, and decreased red blood cell, lymphocyte, and platelet count. Age, neutrophil count, platelet count, and CRP were identified as independent predictors of adverse outcome. The area under the receiver operating characteristic (ROC) curve (AUC) of CRP (0.896) was significantly higher than that of age (0.833), neutrophil count (0.820), and platelet count (0.678) in outcome prediction (all p<0.05). With a cut-off value of 41.4, CRP exhibited sensitivity 90.5%, specificity 77.6%, positive predictive value 61.3%, and negative predictive value 95.4%. Subgroup analysis revealed that CRP remained robust accuracy in adverse outcome prediction in patients with different disease severity (AUC 0.832, z=10.23, p<0.001; AUC 0.989, z=44.04, p<0.001). CRP was also an independent discriminator of severe/critical illness on admission (AUC 0.783, z=10.69, p<0.001). CONCLUSIONS: In patients with COVID-19, admission CRP correlated with disease severity and tended to be a good predictor of adverse outcome."],"journal":"Clin Infect Dis","authors":["Luo, Xiaomin","Zhou, Wei","Yan, Xiaojie","Guo, Tangxi","Wang, Benchao","Xia, Hongxia","Ye, Lu","Xiong, Jun","Jiang, Zongping","Liu, Yu","Zhang, Bicheng","Yang, Weize"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445579","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/cid/ciaa641","keywords":["c-reactive protein","covid-2019","sars-cov-2","prognosis"],"locations":["Wuhan","China","neutrophil"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667600475934949376,"score":181.72974},{"pmid":32259132,"pmcid":"PMC7130449","title":"Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study.","text":["Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study.","Introduction: The role of laboratory parameters in screening of COVID-19 cases has not been definitely established. This study aimed to evaluate the accuracy of laboratory parameters in predicting cases with positive RT-PCR for COVID-19. Methods: This diagnostic accuracy study was conducted on suspected COVID-19 patients, who presented to Behpooyan Clinic Medical center in Tehran (Iran) from 22 February to 14 March, 2020. Patients were divided into two groups based on the results of real time reverse transcriptase-polymerase chain reaction (RT-PCR) for COVID-19, and the accuracy of different laboratory parameters in predicting cases with positive RT-PCR was evaluated using area under the ROC curve (AUC). Results: Two hundred cases with the mean age of 41.3+/- 14.6 (range: 19-78) years were studied (0.53% male). The result of RT-PCR for COVID-19 was positive in 70 (35%) cases. Patients with positive RT-PCR had significantly higher neutrophil (NEU) count (p = 0.0001), and C-reactive protein (CRP) (p = 0.04), lactate dehydrogenase (LDH) (p = 0.0001), aspartate aminotransferase (AST) (p = 0.001), alanine aminotransferase (ALT) (p = 0.0001), and Urea (p = 0.001) levels in serum. In addition, patients with positive RT-PCR had lower white blood cell (WBC) count (p = 0.0001) and serum albumin level (p = 0.0001) compared to others. ALT (AUC = 0.879), CRP (AUC = 0.870), NEU (AUC = 0.858), LDH (AUC = 0.835), and Urea (AUC = 0.835) had very good accuracy in predicting cases with positive RT-PCR for COVID-19, respectively. Conclusion: Our findings suggest that level of LDH, CRP, ALT and NEU can be used to predict the result of COVID-19 test. They can help in detection of COVID-19 patients.","Arch Acad Emerg Med","Mardani, Rajab","Ahmadi Vasmehjani, Abbas","Zali, Fatemeh","Gholami, Alireza","Mousavi Nasab, Seyed Dawood","Kaghazian, Hooman","Kaviani, Mehdi","Ahmadi, Nayebali","32259132"],"abstract":["Introduction: The role of laboratory parameters in screening of COVID-19 cases has not been definitely established. This study aimed to evaluate the accuracy of laboratory parameters in predicting cases with positive RT-PCR for COVID-19. Methods: This diagnostic accuracy study was conducted on suspected COVID-19 patients, who presented to Behpooyan Clinic Medical center in Tehran (Iran) from 22 February to 14 March, 2020. Patients were divided into two groups based on the results of real time reverse transcriptase-polymerase chain reaction (RT-PCR) for COVID-19, and the accuracy of different laboratory parameters in predicting cases with positive RT-PCR was evaluated using area under the ROC curve (AUC). Results: Two hundred cases with the mean age of 41.3+/- 14.6 (range: 19-78) years were studied (0.53% male). The result of RT-PCR for COVID-19 was positive in 70 (35%) cases. Patients with positive RT-PCR had significantly higher neutrophil (NEU) count (p = 0.0001), and C-reactive protein (CRP) (p = 0.04), lactate dehydrogenase (LDH) (p = 0.0001), aspartate aminotransferase (AST) (p = 0.001), alanine aminotransferase (ALT) (p = 0.0001), and Urea (p = 0.001) levels in serum. In addition, patients with positive RT-PCR had lower white blood cell (WBC) count (p = 0.0001) and serum albumin level (p = 0.0001) compared to others. ALT (AUC = 0.879), CRP (AUC = 0.870), NEU (AUC = 0.858), LDH (AUC = 0.835), and Urea (AUC = 0.835) had very good accuracy in predicting cases with positive RT-PCR for COVID-19, respectively. Conclusion: Our findings suggest that level of LDH, CRP, ALT and NEU can be used to predict the result of COVID-19 test. They can help in detection of COVID-19 patients."],"journal":"Arch Acad Emerg Med","authors":["Mardani, Rajab","Ahmadi Vasmehjani, Abbas","Zali, Fatemeh","Gholami, Alireza","Mousavi Nasab, Seyed Dawood","Kaghazian, Hooman","Kaviani, Mehdi","Ahmadi, Nayebali"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259132","source":"PubMed","week":"202015|Apr 06 - Apr 12","keywords":["biochemistry; blood cell count","biomarkers","covid-19","reverse transcriptase polymerase chain reaction","sars-cov-2"],"locations":["Tehran","Iran"],"countries":["Iran, Islamic Republic of"],"countries_codes":["IRN|Iran, Islamic Republic of"],"e_drugs":["Urea"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493176250368,"score":178.55997},{"pmid":32492531,"title":"Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.","text":["Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.","OBJECTIVES: The gold-standard COVID-19 diagnosis relies on detecting SARS-CoV-2 using RNA purification and one-step retrotranscription and quantitative PCR (RT-qPCR). Based on the urgent need for high-throughput screening, we tested the performance of three alternative, simple and affordable protocols to rapidly detect SARS-CoV-2, bypassing the long and tedious RNA extraction step and reducing the time to viral detection. METHODS: We evaluated three methods based on direct nasopharyngeal swab viral transmission medium (VTM) heating before the RT-qPCR: a) direct without additives; b) in a formamide-EDTA (FAE) buffer, c) in a RNAsnap(TM) buffer. RESULTS: Although with a delay in cycle threshold compared to the gold-standard, we found consistent results in nasopharyngeal swab samples that were subject to a direct 70 degrees C incubation for 10 min. CONCLUSIONS: Our findings provide valuable options to overcome any supply chain issue and help to increase the throughput of diagnostic tests, thereby complementing standard diagnosis.","Int J Infect Dis","Alcoba-Florez, Julia","Gonzalez-Montelongo, Rafaela","Inigo-Campos, Antonio","de Artola, Diego Garcia-Martinez","Gil-Campesino, Helena","The Microbiology Technical Support Team","Ciuffreda, Laura","Valenzuela-Fernandez, Agustin","Flores, Carlos","32492531"],"abstract":["OBJECTIVES: The gold-standard COVID-19 diagnosis relies on detecting SARS-CoV-2 using RNA purification and one-step retrotranscription and quantitative PCR (RT-qPCR). Based on the urgent need for high-throughput screening, we tested the performance of three alternative, simple and affordable protocols to rapidly detect SARS-CoV-2, bypassing the long and tedious RNA extraction step and reducing the time to viral detection. METHODS: We evaluated three methods based on direct nasopharyngeal swab viral transmission medium (VTM) heating before the RT-qPCR: a) direct without additives; b) in a formamide-EDTA (FAE) buffer, c) in a RNAsnap(TM) buffer. RESULTS: Although with a delay in cycle threshold compared to the gold-standard, we found consistent results in nasopharyngeal swab samples that were subject to a direct 70 degrees C incubation for 10 min. CONCLUSIONS: Our findings provide valuable options to overcome any supply chain issue and help to increase the throughput of diagnostic tests, thereby complementing standard diagnosis."],"journal":"Int J Infect Dis","authors":["Alcoba-Florez, Julia","Gonzalez-Montelongo, Rafaela","Inigo-Campos, Antonio","de Artola, Diego Garcia-Martinez","Gil-Campesino, Helena","The Microbiology Technical Support Team","Ciuffreda, Laura","Valenzuela-Fernandez, Agustin","Flores, Carlos"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492531","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ijid.2020.05.099","keywords":["covid-19","rna extraction","sars-cov-2","diagnosis","fast protocols","sample treatment"],"topics":["Diagnosis"],"weight":1,"_version_":1668623433626288129,"score":173.44684}]}